Saturn V Capital Management »

Ovid Therapeutics shares owned by Saturn V Capital Management

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Saturn V Capital Management from 13F filings

Historical chart of Saturn V Capital Management investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Saturn V Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Saturn V Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.1M 2.5M 1.63

More positions owned by Saturn V Capital Management

Abivax Sa Sponsored Ads (ABVX)
Amylyx Pharmaceuticals (AMLX)
Cogent Biosciences (COGT)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Vaxcyte (PCVX)
Dyne Therapeutics (DYN)
Pharvaris N V (PHVS)
Celcuity (CELC)
Alumis (ALMS)
Disc Medicine (IRON)
X4 Pharmaceuticals Com New (XFOR)
Monopar Therapeutics Com New (MNPR)
Adagio Therapeutics (IVVD)
Ocular Therapeutix (OCUL)
Immix Biopharma (IMMX)

View all positions for Saturn V Capital Management

Top funds holding Ovid Therapeutics

Takeda Pharmaceutical
Affinity Asset Advisors
ADAR1 Capital Management
Eventide Asset Management
Federated Investors
Point72 Asset Management
Vanguard Group
Saturn V Capital Management
Ally Bridge Group
Renaissance Technologies
Sio Capital Management
Driehaus Capital Management
Adage Capital Partners GP
Marshall Wace
Acadian Asset Management

View all funds holding Ovid Therapeutics